- Previous Close
2.6500 - Open
2.6500 - Bid 2.8550 x --
- Ask 2.9500 x --
- Day's Range
2.4150 - 3.3350 - 52 Week Range
0.8290 - 5.1100 - Volume
863,878 - Avg. Volume
422,410 - Market Cap (intraday)
286.538M - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden.
www.spectracure.comRecent News: SPEC.ST
View MorePerformance Overview: SPEC.ST
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SPEC.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SPEC.ST
View MoreValuation Measures
Market Cap
257.40M
Enterprise Value
235.17M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.31
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-9.54%
Return on Equity (ttm)
-16.50%
Revenue (ttm)
318k
Net Income Avi to Common (ttm)
-21.18M
Diluted EPS (ttm)
-0.2300
Balance Sheet and Cash Flow
Total Cash (mrq)
35.87M
Total Debt/Equity (mrq)
5.19%
Levered Free Cash Flow (ttm)
-25.39M